We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

262 hedge funds and large institutions have $1.53B invested in Select Medical in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 106 increasing their positions, 83 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 83

4% less funds holding

Funds holding: 274262 (-12)

4.6% less ownership

Funds ownership: 82.71%78.12% (-4.6%)

14% less capital invested

Capital invested by funds: $1.78B → $1.53B (-$257M)

18% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 45

Holders
262
Holders Change
-12
Holders Change %
-4.38%
% of All Funds
3.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
37
Increased
106
Reduced
83
Closed
45
Calls
$181K
Puts
Net Calls
+$181K
Net Calls Change
-$398K

SEM Hedge Fund Activity: Q2 2025 in Review

262 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2025, worth a combined $1.53B — down 14% from $1.78B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of SEM and 37 opened new positions — a net loss of 8 holders — while 83 trimmed existing stakes and 106 added.

The largest buyer was 8 Knots Management, opening a new position worth an estimated $27.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $25.1M.

  • 262 institutional investors held Select Medical (SEM) as of Q2 2025, down from 274 in Q1 2025.
  • Funds reported $1.53B of Select Medical stock for Q2 2025, down 14% quarter-over-quarter.
  • 37 funds opened new Select Medical positions in Q2 2025 and 45 closed out, a net change of -8 holders.
  • The largest Select Medical buyer in Q2 2025 was 8 Knots Management, an estimated $27.3M added.
  • The largest Select Medical seller in Q2 2025 was T. Rowe Price Associates, an estimated $25.1M sold.

Based on aggregated 13F filings for Q2 2025.